drugset / Trial / NCT04322227
Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to investigate effects of foliglurax on brain wave patterns (electric signals) in healthy subjects and in patients with PD
Timeline
- Start
- 2020-01-23
- Primary completion
- 2020-05-30
- Completion
- 2020-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Foliglurax | Small molecule | 10 mg | Oral |
| Subject | Foliglurax | Small molecule | 30 mg | Oral |